<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-UAMZG2JH</identifier><date>2002</date><creator>Zadravec-Zaletel, Lorna</creator><relation>documents/doc/U/URN_NBN_SI_doc-UAMZG2JH_001.pdf</relation><relation>documents/doc/U/URN_NBN_SI_doc-UAMZG2JH_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 52-53</format><identifier identifier_type="COBISSID_HOST">15750873</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-UAMZG2JH</identifier><language>slv</language><publisher>Kancerološko združenje Slovenskega zdravniškega društva</publisher><publisher>Onkološki inštitut</publisher><publisher>Zveza slovenskih društev za boj proti raku</publisher><source>Onkološki vikend</source><rights>BY-NC-ND</rights><subject language_type_id="eng">Adult</subject><subject language_type_id="eng">Adverse Effects</subject><subject language_type_id="eng">Antineoplastic Agents</subject><subject language_type_id="slv">Antineoplastiki</subject><subject language_type_id="eng">Diagnosis</subject><subject language_type_id="slv">Limfom folikularni</subject><subject language_type_id="slv">Lymphoma, Follicular</subject><subject language_type_id="slv">Odrasli</subject><subject language_type_id="eng">Therapy</subject><title>Prikaz primera pacientke z ne-Hodgkinovim limfomom (NHL), folikularnim, gradus1, stadij IV B</title></Record>